The Latest Cardiac and Vascular News
SedLine Was Also Associated with Reduction in Bleeding During Surgery and Shorter Duration on Mechanical Ventilation IRVINE, Calif.–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the Journal of Cardiothoracic and Vascular Anesthesia in which Dr. André Denault and colleagues at the Montreal Heart Institute and Centre Hospitalier […]
– The CLEAR ACS trial is designed to evaluate the efficacy of NEXLIZET on short-term LDL-C lowering following those with a recent ACS event and at very high risk of recurrent CV event in a diverse patient population that is often underrepresented in clinical trials – ANN ARBOR, Mich., […]
April 20, 2022 New research proposes a four-stage system for measuring the progression of cardiovascular disease (CAD) based on atherosclerotic plaque – not secondary symptoms of heart disease. Quantification of CAD burden and plaque type has demonstrated to be the strongest discriminant of future risk of Major Adverse Cardiac Events […]
Istaroxime significantly improved the systolic blood pressure profile WARRINGTON, Pa., April 20, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced positive primary results with istaroxime in rapidly raising systolic blood pressure, the […]
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company’s global growth journey NEW DELHI and HECHINGEN, Germany, April 19, 2022 /PRNewswire/ — Translumina, a global developer and manufacturer of innovative cardiovascular medical devices used in interventional cardiology, announces the launch of VIVO ISAR, its latest generation dual drug polymer-free coated stent (DDCS), in […]
JACKSONVILLE, Fla., April 18, 2022 /PRNewswire/ — The American Society for Preventive Cardiology (ASPC) announces the official program for the ASPC 2022 Congress on CVD Prevention, scheduled July 29-31, 2022 in Louisville, KY. The program covers the “ABCs of Preventive Cardiology” over the 2.5 day live, in-person program, and can be found on aspconline.org/2022congress. Included in the […]
Findings suggest that monitoring changes in stroke volume and cardiac output could help predict mortality in critically ill patients Baxter-sponsored symposium advances expert dialogue on fluid management DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a leader in patient monitoring, physical assessment and vision screening products, announced the findings of an observational […]
— Led by director of Penn Cardiovascular Institute (Penn CVI), CHOP CVI combines the best of CHOP and Penn Medicine to drive scientific discovery– PHILADELPHIA, April 18, 2022 /PRNewswire/ — Deepening its commitment to pediatric cardiovascular research, the Children’s Hospital of Philadelphia (CHOP) Research Institute has launched the CHOP Cardiovascular Institute (CHOP CVI). Led by Daniel […]
CareDx Testing Services Have Been Used in Over 30,000 Heart Transplant Patients and Over 90 Percent of Centers in the United States SOUTH SAN FRANCISCO, Calif., April 14, 2022 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, […]
DEDUCE study demonstrates AUC of 0.86 in overall cohort, including more than 700 prospective samples AUSTIN, Texas, April 13, 2022 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that its clinical validation study1 on its donor-derived cell-free DNA (dd-cfDNA) test for the assessment of acute rejection in heart transplant patients, […]
